Browse
Submit Data
Databases
API
Help

Dataset Information

14 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-GEOD-67338

ABSTRACT: Expression data of human neuroblastoma IMR32 cells treated with the DHODH inhibitor Teriflunomide [118 ￂﾵM]

PROVIDER: E-GEOD-67338 | ExpressionAtlas | 2015-06-18

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Similar Datasets

Homo sapiens

Project description:Expression data of human neuroblastoma IMR32 cells treated with the DHODH inhibitor Teriflunomide [118 µM]

| PRJNA279535 | ENA

Transcription profiling of human neuroblastoma samples to identify candidate genes by combining genomic and expression microarrays. Super series see E-GEOD-13136 and E-GEOD-13137

Project description:This SuperSeries is composed of the following subset Series:; GSE13136: Identification of candidate neuroblastoma genes by combining genomic and expression microarrays: expression data; GSE13137: Identification of candidate neuroblastoma genes by combining genomic and expression microarrays: SNP data Experiment Overall Design: Refer to individual Series

2008-10-26 | E-GEOD-13141 | biostudies-arrayexpress

Homo sapiens

Project description:Expression data of human neuroblastoma SK-N-AS treated with the PLK1 inhibitor GSK461364

| PRJNA278960 | ENA

Alteration of treatment of the ALK inhibitor in ALK-amplified neuroblastoma

Project description:Anaplastic Lymphoma Kinase (ALK) most frequently mutated in neuroblastoma (NB) and is atractive molecular target for therapy. However, efficacy of the ALK inhibitor against ALK-amplified NB is unclear. To elucidate genetic alterations induced by treatment of the ALK inhibitor, we compared expression profile between ALK inhibitor-treated and DMSO-treated NB39nu cells using Agilent SurePrint G3 Human GE 8x60K V2 Microarray Kit

2017-11-28 | GSE107354 | GEO

Expression data from SH-SY5Y neuroblastoma cells treated with the protein disulfide isomerase inhibitor origamicin

Project description:Expression data from SH-SY5Y neuroblastoma cells treated with the protein disulfide isomerase inhibitor origamicin

| PRJNA530280 | ENA

ERK inhibitor, ulixertinib induces transcriptomic changes in NGP cells

Project description:To investigate the effect of ERK inhibitor, ulixertinib, on NB cell proliferation and delineate the mechanisms of ulixertinib-mediated ERK pathway inhibition in NB. We treated human neuroblastoma cell line, NGP with ulixertinib and performed gene expression profiling analysis using data obtained from RNA-seq.

2023-03-01 | GSE213153 | GEO

Expression data from neuroblastoma cells treated with MI-773

Project description:Expression data from neuroblastoma cells treated with MI-773

| PRJNA729997 | ENA

H3K27me3 ChIP-seq in SH-SY5Y human neuroblastoma cell line

Project description:H3K27me3 ChIP-seq was performed on: 1) untreated SH-SY5Y human neuroblastoma cells (day 0) 2) vincristine-treated SH-SY5Y human neuroblastoma cells (7 days of treatment - day 7) 3) vincristine-treated SH-SY5Y human neuroblastoma cells (7 days of treatment + 7 days of recover - day 14)

2022-10-01 | E-MTAB-11219 | biostudies-arrayexpress

Homo sapiens

Project description:Expression data from RNAi SNCA treated human neuroblastoma cell line

| PRJNA103753 | ENA

IBL-302 PIM/PI3K/mTOR triple kinase inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells

Project description:neuroblastoma cells derived from PDOX models were treated with the kinase inhibitor.

2019-06-22 | GSE133137 | GEO